FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385989166> ?p ?o ?g. }

• W4385989166 endingPage "386" @default.
• W4385989166 startingPage "372" @default.
• W4385989166 abstract "Recent studies have demonstrated the critical role of cardiac-resident macrophages (cMacs) in the maintenance of physiological homeostasis. However, recruitment of circulating monocyte-derived macrophages decreases cMac levels post-myocardial infarction (MI). Transplanting cMacs is not an ideal option due to their low survival rates and the risk of immunological rejection. However, extracellular vesicle therapy has the potential to provide a feasible and safe alternative for cardiac repair. In this study, cell membrane-modified extracellular vesicles (MmEVs) were developed for heart repair by modifying cMac-derived extracellular vesicles (mEVs) with monocyte membranes, resulting in immune evasion and sequential targeted localization to damaged regions through expression of CD47 on MmEVs and strong affinity between monocyte membrane proteins and CCL2. Additionally, to fully exploit the potential clinical application of MmEVs and achieve a better curative effect, thymosin β4 (Tβ4) was loaded into the nanoparticles, resulting in Tβ4-MmEVs. In vitro experiments indicated that both the MmEVs and Tβ4-MmEVs promoted cardiomyocyte proliferation and endothelial cell migration. Animal experiments suggested that MI mice treated with MmEVs and Tβ4-MmEVs exhibited reduced myocardial fibrosis and increased vascular density compared to the control group. Thus, we posit that these targeted nanoparticles hold significant potential for MI adjuvant therapy and may open new avenues for cardiac repair and regeneration. STATEMENT OF SIGNIFICANCE: Extracellular vesicles (EVs) derived from bioactive parent cell sources involved in pathological and repair processes for cardiovascular disease have emerged as a compelling strategy for regenerative therapy. In this study, we constructed monocyte membrane-modified extracellular vesicles loaded with a drug (Tβ4-MmEVs) for heart repair that exhibit extraordinary abilities of immune evasion and sequential localization to damaged regions owing to the presence of CD47 and the strong affinity between monocytes and damaged cardiomyocytes and endothelial cells. The bioactivities of Tβ4-MmEVs on enhancing cardiomyocyte and endothelial cell proliferation were validated both in vitro and in vivo. Effective development and implementation of therapeutically membrane-modified nanoparticles from homologous origins can provide a reference for adjuvant therapy in clinical MI management." @default.
• W4385989166 created "2023-08-19" @default.
• W4385989166 creator A5013550234 @default.
• W4385989166 creator A5014507212 @default.
• W4385989166 creator A5030934381 @default.
• W4385989166 creator A5031796503 @default.
• W4385989166 creator A5037531575 @default.
• W4385989166 creator A5039625518 @default.
• W4385989166 creator A5050076476 @default.
• W4385989166 creator A5061590421 @default.
• W4385989166 creator A5071065887 @default.
• W4385989166 creator A5075191597 @default.
• W4385989166 creator A5083192709 @default.
• W4385989166 creator A5085217855 @default.
• W4385989166 creator A5085634071 @default.
• W4385989166 date "2023-10-01" @default.
• W4385989166 modified "2023-10-15" @default.
• W4385989166 title "Targeted heart repair by Tβ4-loaded cardiac-resident macrophage-derived extracellular vesicles modified with monocyte membranes" @default.
• W4385989166 cites W1954373103 @default.
• W4385989166 cites W1999917818 @default.
• W4385989166 cites W2005400104 @default.
• W4385989166 cites W2010484682 @default.
• W4385989166 cites W2040635479 @default.
• W4385989166 cites W2066843867 @default.
• W4385989166 cites W2152533590 @default.
• W4385989166 cites W2307209901 @default.
• W4385989166 cites W2588049964 @default.
• W4385989166 cites W2883126472 @default.
• W4385989166 cites W2890977746 @default.
• W4385989166 cites W2891218377 @default.
• W4385989166 cites W2902050841 @default.
• W4385989166 cites W2904624968 @default.
• W4385989166 cites W2908128192 @default.
• W4385989166 cites W2914657608 @default.
• W4385989166 cites W2949648051 @default.
• W4385989166 cites W2974291499 @default.
• W4385989166 cites W2980637827 @default.
• W4385989166 cites W3000102939 @default.
• W4385989166 cites W3001514843 @default.
• W4385989166 cites W3014730208 @default.
• W4385989166 cites W3028854163 @default.
• W4385989166 cites W3033030716 @default.
• W4385989166 cites W3038370605 @default.
• W4385989166 cites W3092269784 @default.
• W4385989166 cites W3094125068 @default.
• W4385989166 cites W3112167115 @default.
• W4385989166 cites W3138784463 @default.
• W4385989166 cites W3138926548 @default.
• W4385989166 cites W3159735398 @default.
• W4385989166 cites W3183753432 @default.
• W4385989166 cites W3210311770 @default.
• W4385989166 cites W4210742222 @default.
• W4385989166 cites W4229062766 @default.
• W4385989166 cites W4252019796 @default.
• W4385989166 cites W4285156288 @default.
• W4385989166 cites W4289528160 @default.
• W4385989166 cites W4297963228 @default.
• W4385989166 cites W4319294591 @default.
• W4385989166 cites W4319660217 @default.
• W4385989166 doi "https://doi.org/10.1016/j.actbio.2023.08.022" @default.
• W4385989166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37597679" @default.
• W4385989166 hasPublicationYear "2023" @default.
• W4385989166 type Work @default.
• W4385989166 citedByCount "0" @default.
• W4385989166 crossrefType "journal-article" @default.
• W4385989166 hasAuthorship W4385989166A5013550234 @default.
• W4385989166 hasAuthorship W4385989166A5014507212 @default.
• W4385989166 hasAuthorship W4385989166A5030934381 @default.
• W4385989166 hasAuthorship W4385989166A5031796503 @default.
• W4385989166 hasAuthorship W4385989166A5037531575 @default.
• W4385989166 hasAuthorship W4385989166A5039625518 @default.
• W4385989166 hasAuthorship W4385989166A5050076476 @default.
• W4385989166 hasAuthorship W4385989166A5061590421 @default.
• W4385989166 hasAuthorship W4385989166A5071065887 @default.
• W4385989166 hasAuthorship W4385989166A5075191597 @default.
• W4385989166 hasAuthorship W4385989166A5083192709 @default.
• W4385989166 hasAuthorship W4385989166A5085217855 @default.
• W4385989166 hasAuthorship W4385989166A5085634071 @default.
• W4385989166 hasBestOaLocation W43859891661 @default.
• W4385989166 hasConcept C203014093 @default.
• W4385989166 hasConcept C2781184567 @default.
• W4385989166 hasConcept C28406088 @default.
• W4385989166 hasConcept C502942594 @default.
• W4385989166 hasConcept C86803240 @default.
• W4385989166 hasConcept C8891405 @default.
• W4385989166 hasConcept C95444343 @default.
• W4385989166 hasConceptScore W4385989166C203014093 @default.
• W4385989166 hasConceptScore W4385989166C2781184567 @default.
• W4385989166 hasConceptScore W4385989166C28406088 @default.
• W4385989166 hasConceptScore W4385989166C502942594 @default.
• W4385989166 hasConceptScore W4385989166C86803240 @default.
• W4385989166 hasConceptScore W4385989166C8891405 @default.
• W4385989166 hasConceptScore W4385989166C95444343 @default.
• W4385989166 hasFunder F4320321001 @default.
• W4385989166 hasFunder F4320321543 @default.
• W4385989166 hasFunder F4320337111 @default.
• W4385989166 hasLocation W43859891661 @default.
• W4385989166 hasLocation W43859891662 @default.

• next